Showing results (21-30 of 43) with videos related to

Sort By:
Pageof 5
International Journal of Hematology|January 7, 2018
Deferasirox for the treatment of iron overload after allogeneic hematopoietic cell transplantation: multicenter phase I study (KSGCT1302)Takayoshi Tachibana, Junya Kanda, Shinichiro Machida, et al.
International Journal of Hematology|August 11, 2017
NKG2D gene polymorphisms are associated with disease control of chronic myeloid leukemia by dasatinibRyujiro Hara, Makoto Onizuka, Erika Matsusita, et al.
International Journal of Hematology|January 19, 2017
Successful treatment with low-dose nivolumab in refractory Hodgkin lymphoma after allogeneic stem cell transplantationMakoto Onizuka, Minoru Kojima, Keiko Matsui, et al.
Blood Cell Therapy|December 26, 2023
Association of CDKN2A/2B deletion with relapse after hematopoietic stem cell transplantation for acute lymphoblastic leukemiaMakoto Onizuka, Eri Kikkawa, Shinichiro Machida, et al.
Scientific Reports|February 14, 2023
Donor cord blood aging accelerates in recipients after transplantationMakoto Onizuka, Tadashi Imanishi, Kaito Harada, et al.
Journal of Infection and Chemotherapy : Official Journal of the Japan Society of Chemotherapy|June 12, 2022
Risk factors for lower respiratory tract disease and outcomes in allogeneic hematopoietic stem cell transplantation recipients with influenza virus infectionSawako Shiraiwa, Kaito Harada, Makoto Onizuka, et al.
Internal Medicine (Tokyo, Japan)|October 22, 2025
Successful Treatment of Chronic Active Epstein-Barr Virus Infection Complicated by Cardiomyopathy in an Adult PatientKaito Harada, Shino Iwata, Shinichiro Machida, et al.
Leukemia Research Reports|May 5, 2016
Refractory acute promyelocytic leukemia successfully treated with combination therapy of arsenic trioxide and tamibarotene: A case reportMinoru Kojima, Daisuke Ogiya, Akifumi Ichiki, et al.
International Journal of Hematology|February 7, 2019
Phase II study of FLAGM (fludarabine + high-dose cytarabine + granulocyte colony-stimulating factor + mitoxantrone) for relapsed or refractory acute myeloid leukemiaNahoko Hatsumi, Shuichi Miyawaki, Takahiro Yamauchi, et al.
Leukemia & Lymphoma|December 25, 2025
Cord blood versus bone marrow/peripheral blood stem cell transplantation under reduced-intensity conditioning in high-risk acute myeloid leukemia and myelodysplastic syndromesKaito Harada, Shino Iwata, Shunsuke Tomita, et al.
Pageof 5